ReviewPharmacoEconomics2012

New clinical insights into chronic obstructive pulmonary disease and their implications for pharmacoeconomic analyses.

Douglas W Mapel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.